Published in Hum Reprod Update on September 11, 2008
Male infertility: a risk factor for testicular cancer. Nat Rev Urol (2009) 1.02
Insurance coverage for male infertility care in the United States. Asian J Androl (2016) 0.91
The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies. Stem Cells Transl Med (2012) 0.84
Male reproductive health and prostate cancer risk. Curr Opin Urol (2011) 0.81
Social oocyte freezing. Facts Views Vis Obgyn (2010) 0.78
Cumulative delivery rate after providing full reimbursement in vitro fertilization programme: a 6-years survey. Biomed Res Int (2014) 0.78
Demographic relevancy of increased use of assisted reproduction in European countries. Reprod Health (2014) 0.77
Letter to the editor of Human Reproduction Update. Re: Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update (2009) 0.75
Causes of Sterility in Bosnia-Herzegovina Population. Mater Sociomed (2015) 0.75
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod (2004) 3.56
Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update (2008) 3.31
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod Biomed Online (2011) 2.79
Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet (2005) 2.73
In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med (2006) 2.41
Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod (2006) 2.18
Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil Steril (2002) 2.16
Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril (2005) 2.09
Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod (2002) 1.98
A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril (2011) 1.85
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod (2007) 1.82
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril (2006) 1.81
Primary ovarian insufficiency. Lancet (2010) 1.67
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod (2007) 1.66
Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online (2006) 1.56
Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online (2011) 1.51
Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod (2004) 1.47
Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod (2002) 1.46
Are ICSI adolescents at risk for increased adiposity? Hum Reprod (2011) 1.45
The endometrium in stimulated cycles for IVF. Hum Reprod Update (2004) 1.44
"Floating denominators"--effect of verification bias on accuracy estimates for preimplantation diagnosis. Fertil Steril (2003) 1.39
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril (2003) 1.32
Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril (2002) 1.31
Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril (2005) 1.24
Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod (2005) 1.23
Influence of individual sperm morphology on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic sperm injection. Fertil Steril (2003) 1.20
Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab (2003) 1.19
Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects. Hum Reprod Update (2004) 1.17
Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril (2010) 1.15
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. Reprod Biomed Online (2011) 1.15
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril (2004) 1.14
Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod (2004) 1.12
Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab (2003) 1.11
Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertil Steril (2005) 1.10
Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod (2003) 1.05
Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod (2009) 1.05
Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod (2004) 1.05
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril (2007) 1.04
Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. Reprod Biomed Online (2006) 1.04
In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. Hum Reprod (2009) 1.03
Ex-vivo oocyte retrieval for fertility preservation. Fertil Steril (2010) 1.02
Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod (2006) 1.01
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology. Gynecol Endocrinol (2015) 1.01
Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reprod Biomed Online (2003) 1.01
The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum Reprod (2008) 0.98
Thyroid dysfunction and autoimmunity in infertile women. Thyroid (2002) 0.98
Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online (2004) 0.98
Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod (2007) 0.98
Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril (2011) 0.97
Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril (2012) 0.97
Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. Fertil Steril (2012) 0.97
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod (2005) 0.96
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril (2003) 0.96
Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod (2007) 0.96
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online (2011) 0.95
Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles. Fertil Steril (2004) 0.94
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril (2007) 0.94
Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab (2004) 0.93
Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors. Fertil Steril (2012) 0.93
Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod (2002) 0.92
The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing. Hum Reprod (2008) 0.92
Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online (2006) 0.91
Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril (2002) 0.90
Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod Biomed Online (2008) 0.90
Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer. Reprod Biol Endocrinol (2007) 0.90
HLA-G expression in human embryonic stem cells and preimplantation embryos. J Immunol (2011) 0.90
Slow controlled-rate freezing of sequentially cultured human blastocysts: an evaluation of two freezing strategies. Hum Reprod (2005) 0.90
Cumulative delivery rates after ICSI in women aged >37 years. Hum Reprod (2002) 0.89
New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil Steril (2012) 0.89
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril (2005) 0.89
Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis. Reprod Biol Endocrinol (2012) 0.88
Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertil Steril (2009) 0.88
Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. Fertil Steril (2004) 0.88
Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab (2003) 0.88
Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. Fertil Steril (2002) 0.87
Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. Fertil Steril (2004) 0.86
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril (2006) 0.86
The luteal phase after ovarian stimulation. Reprod Biomed Online (2002) 0.86
Estrogen and folliculogenesis: is one necessary for the other? Curr Opin Obstet Gynecol (2005) 0.86
Outcome for donors and recipients in two egg-sharing policies. Fertil Steril (2003) 0.86
A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception. J Clin Endocrinol Metab (2005) 0.85
Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes. Fertil Steril (2007) 0.85
Blastocyst culture: facts and fiction. Reprod Biomed Online (2002) 0.84
Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3? Reprod Biol Endocrinol (2011) 0.84
Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. Fertil Steril (2003) 0.84
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone. Fertil Steril (2012) 0.83
Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online (2008) 0.83
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. Fertil Steril (2010) 0.83
Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child. Eur J Hum Genet (2009) 0.83
Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles. Eur J Obstet Gynecol Reprod Biol (2010) 0.83
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertil Steril (2003) 0.83
Spontaneous pregnancies in couples who discontinued intracytoplasmic sperm injection treatment: a 5-year follow-up study. Fertil Steril (2002) 0.83
Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril (2003) 0.82